Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session on The Emergence of Omicron: A Variant of Concern - By Dr. Ashwini.
Dr. Ashwini discusses the emergence of Omicron, a variant of concern of the SARS-CoV-2 virus, which was first identified in South Africa in late 2021. Omicron quickly gained global attention due to its unprecedented number of mutations in the spike protein, raising concerns about increased transmissibility and potential resistance to existing vaccines and treatments.
Omicron's rapid spread has been attributed to its ability to evade immunity from previous infections and vaccinations more effectively than earlier variants. Dr. Ashwini highlights that, despite its higher transmissibility, preliminary data suggested that Omicron might cause less severe disease compared to the Delta variant. However, the sheer volume of cases posed significant challenges to healthcare systems worldwide, leading to increased hospitalizations and strain on medical resources.
To combat Omicron, Dr. Ashwini emphasizes the importance of booster vaccination campaigns, which have shown to enhance protection against this variant. Additionally, ongoing research and adaptation of COVID-19 treatments and preventive measures are crucial in addressing the evolving threat posed by Omicron and future variants. Public health strategies, including widespread testing, genomic surveillance, and reinforcing public health measures, remain essential in mitigating the impact of Omicron.
Therefore, get an overall knowledge of Th
See More Webinars @ Hidoc Webinars
1.
Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment
2.
A small rise in cancer was observed following the 1986 Chernobyl accident.
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
1.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
2.
Survivorship Planning Beyond Active Cancer Care
3.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
4.
Integrated Models in Hematology for Specialists
5.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation